Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
earnings-estimates-revisions: Archive
Is It Worth Investing in Allstate (ALL) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Allstate (ALL). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
ALLPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in PulteGroup (PHM) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for PulteGroup (PHM) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
PHMPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts See Emerson Electric (EMR) as a Buy: Should You Invest?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Emerson Electric (EMR) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
EMRNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Riot Platforms, Inc. (RIOT) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Riot Platforms, Inc. (RIOT) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
RIOTNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Should You Invest in Amkor Technology (AMKR) Based on Bullish Wall Street Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Amkor Technology (AMKR) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
AMKRNo Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Skechers (SKX): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Skechers (SKX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
SKXNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts See Tenet (THC) as a Buy: Should You Invest?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Tenet (THC). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
THCNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
ANI (ANIP) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for ANI (ANIP) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
ANIPPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
DigitalOcean (DOCN) Reports Q1 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for DigitalOcean (DOCN) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
DOCNPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Brokers Suggest Investing in SkyWest (SKYW): Read This Before Placing a Bet
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in SkyWest (SKYW). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
SKYWPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About Valero Energy (VLO): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Valero Energy (VLO) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
VLONegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Here's What Key Metrics Tell Us About Oportun Financial (OPRT) Q1 Earnings
by Zacks Equity Research
While the top- and bottom-line numbers for Oportun Financial (OPRT) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
OPRTPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Evolent Health (EVH) Reports Q1 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Evolent Health (EVH) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
EVHNegative Net Change
earnings earnings-estimates-revisions earnings-surprise
Here's What Key Metrics Tell Us About Deciphera Pharmaceuticals (DCPH) Q1 Earnings
by Zacks Equity Research
While the top- and bottom-line numbers for Deciphera Pharmaceuticals (DCPH) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
DCPHNegative Net Change
earnings earnings-estimates-revisions earnings-surprise
Compared to Estimates, AirSculpt Technologies (AIRS) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for AirSculpt Technologies (AIRS) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
AIRSNegative Net Change
earnings earnings-estimates-revisions earnings-surprise
Arhaus, Inc. (ARHS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for Arhaus, Inc. (ARHS) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
ARHSPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
AMC Networks (AMCX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for AMC Networks (AMCX) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
AMCXNegative Net Change
earnings earnings-estimates-revisions earnings-surprise
Compared to Estimates, Sweetgreen (SG) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Sweetgreen (SG) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
SGPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Amicus Therapeutics (FOLD) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
The headline numbers for Amicus Therapeutics (FOLD) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
FOLDNegative Net Change
earnings earnings-estimates-revisions earnings-surprise
GoodRx (GDRX) Reports Q1 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for GoodRx (GDRX) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
GDRXNegative Net Change
earnings earnings-estimates-revisions earnings-surprise
Epam (EPAM) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
The headline numbers for Epam (EPAM) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
EPAMPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Compared to Estimates, Legacy Housing (LEGH) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Legacy Housing (LEGH) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
LEGHPositive Net Change
earnings earnings-estimates-revisions earnings-surprise
Wheaton Precious Metals (WPM) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Wheaton Precious Metals (WPM) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
WPMNegative Net Change
earnings earnings-estimates-revisions earnings-surprise
Ziff Davis (ZD) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Ziff Davis (ZD) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
ZDNegative Net Change
earnings earnings-estimates-revisions earnings-surprise
Americold Realty Trust (COLD) Reports Q1 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for Americold Realty Trust (COLD) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
COLDPositive Net Change
earnings earnings-estimates-revisions earnings-surprise